New drugs for treating small cell lung cancer

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Recently there has been a number of new active drugs which have been identified for treating patients with SCLC. These drugs include paclitaxel, docetaxel, CPT-11, topotecan and gemcitabine. The range of response rates are as follows for each of the drugs given: (1) to previously untreated patients: paclitaxel (34–41%), topotecan (39%) and gemcitabine (30%), and (2) to previously treated patients: docetaxel (28%), CPT-11 (47%) and topotecan (35%). Further studies with these new drugs utilized in combination chemo therapeutic regimens are needed to define the role of these agents in the treatment of patients with SCLC.

Original languageEnglish (US)
Pages (from-to)S53-S61
JournalLung Cancer
StatePublished - 1995


  • CPT-11
  • Chemotherapy
  • Docetaxel
  • Gemcitabine
  • Paclitaxel
  • Small cell lung cancer
  • Topotecan

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research


Dive into the research topics of 'New drugs for treating small cell lung cancer'. Together they form a unique fingerprint.

Cite this